Early Promise for New Agent in Congenital Hyperinsulinism in Kids Early Promise for New Agent in Congenital Hyperinsulinism in Kids

Exendin-(9-39) may offer some children born with this rare disease, which results in excessively low blood glucose, an alternative to near-total pancreatectomy.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news